Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asimadoline in irritable bowel syndrome with diarrhea
jRCT2080221823Phase 2
- Sponsor
- Ono Pharmaceutical
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Diarrhea-predominant irritable bowel syndrome (IBS-D) comparing Asimadoline with Placebo (2 arms).
02
Drugs
asimadoline
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on jRCT2080221823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221823.